Concepedia

Emma M. Bonniwell

EM

Statistics

Publications

5

Citations

381

H-Index

5

Active since

2022

Affiliations

Medical College of Wisconsin(Current)

University of California San Diego

Usona Institute

VA San Diego Healthcare System

Saint Joseph's University

Emma M. Bonniwell is an author at Medical College of Wisconsin specializing in psychopharmacology, neuropharmacology, and pharmacology.

ORCID

Publications per year

2022–2023

5

Publications

5

Identification of 5-HT2A receptor signaling pathways associated with psychedelic potential

Jason Wallach, Andrew B. Cao, Maggie M. Calkins et al. · Nature Communications · 2023 · 151 citations · Full text

, , +11

A non-hallucinogenic LSD analog with therapeutic potential for mood disorders

Vern Lewis, Emma M. Bonniwell, Janelle K. Lanham et al. · Cell Reports · 2023 · 128 citations · Full text

, , +10

Pharmacological Mechanism of the Non-hallucinogenic 5-HT<sub>2A</sub> Agonist Ariadne and Analogs

Michael J. Cunningham, Hailey A. Bock, Inis C. Serrano et al. · ACS Chemical Neuroscience · 2022 · 65 citations · Full text

, , +11

Psilocybin analog 4-OH-DiPT enhances fear extinction and GABAergic inhibition of principal neurons in the basolateral amygdala

Thomas J. Kelly, Emma M. Bonniwell, Lianwei Mu et al. · Neuropsychopharmacology · 2023 · 26 citations · Full text

, , +17

Identification of 5-HT <sub>2A</sub> Receptor Signaling Pathways Responsible for Psychedelic Potential

Jason Wallach, Andrew B. Cao, Maggie M. Calkins et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2023 · 11 citations · Full text

, , +11

1–5 of 5